'Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' - Author's reply

Clin Microbiol Infect. 2021 Jul;27(7):1045. doi: 10.1016/j.cmi.2021.05.019. Epub 2021 May 15.

Authors

Martin Wolkewitz¹, Maja von Cube², Oksana Martinuka²

Affiliations

¹ Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Centre, University of Freiburg, Freiburg, Germany. Electronic address: wolke@imbi.uni-freiburg.de.
² Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Centre, University of Freiburg, Freiburg, Germany.

No abstract available

Publication types

Letter
Comment

MeSH terms

Bias
COVID-19*
Humans
Pharmaceutical Preparations*
SARS-CoV-2

Substances

Pharmaceutical Preparations